Correlation Between Legend Biotech and Ascendis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Ascendis Pharma AS, you can compare the effects of market volatilities on Legend Biotech and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Ascendis Pharma.

Diversification Opportunities for Legend Biotech and Ascendis Pharma

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Legend and Ascendis is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Legend Biotech i.e., Legend Biotech and Ascendis Pharma go up and down completely randomly.

Pair Corralation between Legend Biotech and Ascendis Pharma

Given the investment horizon of 90 days Legend Biotech is expected to generate 21.03 times less return on investment than Ascendis Pharma. But when comparing it to its historical volatility, Legend Biotech Corp is 1.1 times less risky than Ascendis Pharma. It trades about 0.0 of its potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  12,147  in Ascendis Pharma AS on September 4, 2024 and sell it today you would earn a total of  1,204  from holding Ascendis Pharma AS or generate 9.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Legend Biotech Corp  vs.  Ascendis Pharma AS

 Performance 
       Timeline  
Legend Biotech Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ascendis Pharma AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Ascendis Pharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Legend Biotech and Ascendis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Legend Biotech and Ascendis Pharma

The main advantage of trading using opposite Legend Biotech and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.
The idea behind Legend Biotech Corp and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation